No need for apologies Buckland ,, we are all entitled to our opinions and HC is a Public Forum to express those opinions..
You are correct the Phase I MND data was the primary catalyst for the run up in value and MT did allude to a possible early partnership but we live in uncertain times.
As for not delivering ,,, you know how much ground work has to be done before you see any results,,, imagine an Architect , before a single stone is turned on site the entire building is drafted, the fundamentals first Bucky , Geo work to make sure the ground will hold the structure and a decent foundation are the key...
From my position I can see how NUZ could literally have an explosive expansion into other Neurological Diseases..
The chock under the wheel is the FDA granting the IND,, and the market are aware that the future Phase II will require funding,,,, it would seem that Management are several steps ahead.... MT has personally made it clear that Management are aware and are disappointed themselves that the FDA IND granting was not smooth..
Keep in mind a significant group of Management have purchased significant parcels of shares on market funded from their own purse...
I appreciate your position and enjoy your posts , it brings balance to the Forum ,,, but when NUZ runs past 60c will you then give MT and Management a thumbs up?? NZT
NUZ Price at posting:
17.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)